Lead pre and post launch activities to create a treatment home for children with Achondroplasia (Voxzogo) to Geneticists, Pediatric Endocrinologists and General Pediatricians across Michigan, N. Indiana, and Chicago. Manage the steps and personnel needed to get patients consented, enrolled, and started on therapy. Prepared Michigan hemophilia centers in 2020 for the future approval of gene therapy infusions (Roctavian). *Developed a new KOL to be one of the top Ped Endocrinologist prescribers in the U.S. * #1 national rank in Ped Endocrinologists enrolled in Doctor finder website.* Finalist for Q3 '22 Ped Endo new start award.* Coordinated cross specialty meetings between Genetics and Ped Endo to streamline treatment pathways for rapid market uptake. *Facilitated EMR & ICD10 searches with specialists to identify new and lost to follow up patients. *Dramatically increased sponsored genetic testing program utilization through targeted presentations to pediatrics to increase diagnosis and accelerate insurance approvals. *Selected as regional super user of salesforce.com and Komodo database.

Successfully launched two new Neurology indications for Soliris in Neuromyelitis Optica and Myasthenia Gravis as well as previously driving Hematology, Nephrology, and BMT sales in PNH and AHUS disease states. * Presidents Club award winner and #1 national sales rank in first full year with company. * Longest consecutive streak of new patient starts/finds (13 straight quarters) for the ultra rare disease PNH (10 people per million).* Achieved repeated top 20 % national sales rankings and "Exceeds expectations" ratings for both Neurology and Hematology/Nephrology/BMT teams.*Chosen as Marketing Champion representative for the region in five consecutive years serving as a corporate marketing liaison. *Served as a guest speaker for National Sales Meetings and multiple new hire sales training classes and served as the regional mentor to multiple new hires.

Launched Dacogen for MDS and drove market share for Aloxi (chemo induced nausea) to cancer centers across S.E. Michigan. Achieved top 20% national sales rankings in multiple years. Winner of District Human Health Care Award for community service. Also launched Lusedra (anesthetic) with 205% to quota attainment. Exceeded sales goals every year selling the brain tumor implant Gliadel to Neurosurgeons and Neuro-oncologists across Michigan.